NeuroSense Therapeutics to Participate in BIO-Europe Spring

NeuroSense Therapeutics announced its Chief Medical Officer Dr. Ferenc Tracik and VP of Business Development Nedira Salzman-Frenkel will participate in the 17th annual BIO-Europe Spring partnering conference on March 20-22, 2023 in Basel, Switzerland.

Dr. Tracik and Ms. Salzman-Frenkel are scheduled to meet with potential strategic partners and collaborators regarding NeuroSense’s advancing development pipeline.


Join Our Newsletter

Skip to content